Advocacy Committee
Join community members to support the City Council funded Viral Hepatitis Initiative and to advocate for other local, state, or federal policy and legislative issues.
Goals:
- Educate City Council members on the impact of the Viral Hepatitis Initiative
- Share information with community members, staff from community-based organizations focused on harm reduction, syringe exchange, drug user health, immigrant and foreign-born populations, people with HIV/AIDS, and others at risk of viral hepatitis regarding advocacy and legislative issues
- Provide information to the HepFreeNYC community regarding state and federal legislative issues
Support the committee efforts by sharing our content, and following us on social media!
Related Advocacy Posts
NY City Council Discretionary Funding Application | Due 2/19/2021
Organizations wishing to receive City Council funding in FY 2022 must complete Discretionary Funding application by February 19, 2021.
NYC Council Viral Hepatitis Initiative
NYC Council established the Viral Hepatitis Initiative in 2014, to fund community organizations to provide hepatitis B and C prevention, linkage to care and care services.
Hep C Medication Prior Authorization Requirements Reduced in NYS Fee for Service Medicaid
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
Hepatitis A, B and C in New York City: 2019 Annual Report
The Hepatitis A, B and C in NYC: 2019 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
NYS 2020 Viral Hepatitis Strategic Plan (NYS DOH)
The NYS Viral Hepatitis Strategic Plan outlines a coordinated, comprehensive, and systematic approach that will decrease the incidence and reduce the morbidity and mortality of viral hepatitis.
Hep Free NYC Advocacy Committee Meeting Highlights | 09-23-2020
Meeting of community partners to discuss local, State, and Federal advocacy initiatives.
